GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (STU:0NF0) » Definitions » Pretax Margin %

Mydecine Innovations Group (STU:0NF0) Pretax Margin % : % (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Mydecine Innovations Group Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Mydecine Innovations Group's Pre-Tax Income for the three months ended in Sep. 2023 was €-7.75 Mil. Mydecine Innovations Group's Revenue for the three months ended in Sep. 2023 was €0.00 Mil. Therefore, Mydecine Innovations Group's pretax margin for the quarter that ended in Sep. 2023 was %.

The historical rank and industry rank for Mydecine Innovations Group's Pretax Margin % or its related term are showing as below:


STU:0NF0's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.245
* Ranked among companies with meaningful Pretax Margin % only.

Mydecine Innovations Group Pretax Margin % Historical Data

The historical data trend for Mydecine Innovations Group's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Pretax Margin % Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,424.26 -17,029.07 -862,350.00 -326,100.00 -

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mydecine Innovations Group's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Pretax Margin % falls into.



Mydecine Innovations Group Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Mydecine Innovations Group's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-11.981/0
= %

Mydecine Innovations Group's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-7.75/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mydecine Innovations Group  (STU:0NF0) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Mydecine Innovations Group Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group (STU:0NF0) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (STU:0NF0) Headlines

No Headlines